Literature DB >> 25620121

Endogenous oxytocin levels are associated with the perception of emotion in dynamic body expressions in schizophrenia.

Gregory P Strauss1, William R Keller2, James I Koenig2, Sara K Sullivan3, James M Gold2, Robert W Buchanan2.   

Abstract

Lower endogenous oxytocin levels have been associated with impaired social cognition in schizophrenia, particularly facial affect identification. Little is known about the relationship between oxytocin and other forms of emotion perception. In the current study, 41 individuals with schizophrenia (SZ) and 22 demographically matched healthy controls (CN) completed a forced-choice affective body expression classification task. Stimuli included dynamic videos of male and female actors portraying 4 discrete emotions: happiness, sadness, anger, and neutral. Plasma oxytocin levels were determined via radioimmunoassay. Results indicated that SZ had significantly higher plasma oxytocin concentrations than CN. SZ were also less accurate at identifying expressions of happiness and sadness; however, there were no group differences for anger or neutral stimuli. A group×sex interaction was also present, such that female CN were more accurate than male CN, whereas male SZ were more accurate than female SZ. Higher endogenous oxytocin levels were associated with better total recognition in both SZ and CN; this association was specific to females in SZ. Findings indicate that sex plays an important role in identifying emotional expressions in body gestures in SZ, and that individual differences in endogenous oxytocin predict emotion perception accuracy.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Emotion; Emotion perception; Oxytocin; Psychosis; Schizophrenia

Mesh:

Substances:

Year:  2015        PMID: 25620121      PMCID: PMC4339450          DOI: 10.1016/j.schres.2015.01.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  24 in total

1.  The brief negative symptom scale: psychometric properties.

Authors:  Brian Kirkpatrick; Gregory P Strauss; Linh Nguyen; Bernard A Fischer; David G Daniel; Angel Cienfuegos; Stephen R Marder
Journal:  Schizophr Bull       Date:  2010-06-17       Impact factor: 9.306

2.  Improving social perception in schizophrenia: the role of oxytocin.

Authors:  M Fischer-Shofty; M Brüne; A Ebert; D Shefet; Y Levkovitz; S G Shamay-Tsoory
Journal:  Schizophr Res       Date:  2013-02-19       Impact factor: 4.939

3.  Sex-specific associations between peripheral oxytocin and emotion perception in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren Drogos; Rhoda Jamadar; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2011-06-17       Impact factor: 4.939

4.  Intranasal oxytocin reduces psychotic symptoms and improves Theory of Mind and social perception in schizophrenia.

Authors:  Cort A Pedersen; Clare M Gibson; Shane W Rau; Kayvon Salimi; Kelly L Smedley; Robin L Casey; Jane Leserman; L Fredrik Jarskog; David L Penn
Journal:  Schizophr Res       Date:  2011-08-15       Impact factor: 4.939

5.  Perceiving emotions from bodily expressions and multisensory integration of emotion cues in schizophrenia.

Authors:  Jan Van den Stock; Sjakko J de Jong; Paul P G Hodiamont; Beatrice de Gelder
Journal:  Soc Neurosci       Date:  2011-07-22       Impact factor: 2.083

6.  Divergent effects of two different doses of intranasal oxytocin on facial affect discrimination in schizophrenic patients with and without polydipsia.

Authors:  Morris B Goldman; Alexandrina M Gomes; C S Carter; Royce Lee
Journal:  Psychopharmacology (Berl)       Date:  2011-02-09       Impact factor: 4.530

7.  Diagnostic criteria and five-year outcome in schizophrenia. A report from the International Pilot Study of schizophrenia.

Authors:  A B Hawk; W T Carpenter; J S Strauss
Journal:  Arch Gen Psychiatry       Date:  1975-03

8.  Factor structure of the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; L Elliot Hong; James M Gold; Robert W Buchanan; Robert P McMahon; William R Keller; Bernard A Fischer; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2012-10-09       Impact factor: 4.939

9.  Facial emotion perception in schizophrenia: a meta-analytic review.

Authors:  Christian G Kohler; Jeffrey B Walker; Elizabeth A Martin; Kristin M Healey; Paul J Moberg
Journal:  Schizophr Bull       Date:  2009-03-27       Impact factor: 9.306

10.  Next-generation negative symptom assessment for clinical trials: validation of the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; William R Keller; Robert W Buchanan; James M Gold; Bernard A Fischer; Robert P McMahon; Lauren T Catalano; Adam J Culbreth; William T Carpenter; Brian Kirkpatrick
Journal:  Schizophr Res       Date:  2012-11-03       Impact factor: 4.939

View more
  20 in total

Review 1.  Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.

Authors:  Ellen R Bradley; Joshua D Woolley
Journal:  Neurosci Biobehav Rev       Date:  2017-05-12       Impact factor: 8.989

2.  Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2015-05-16       Impact factor: 4.939

3.  Relationship of plasma oxytocin levels to baseline symptoms and symptom changes during three weeks of daily oxytocin administration in people with schizophrenia.

Authors:  Mary R Lee; Heidi J Wehring; Robert P McMahon; Fang Liu; Jared Linthicum; Joseph G Verbalis; Robert W Buchanan; Gregory P Strauss; Leah H Rubin; Deanna L Kelly
Journal:  Schizophr Res       Date:  2016-02-12       Impact factor: 4.939

Review 4.  Potential of Oxytocin in the Treatment of Schizophrenia.

Authors:  Paul D Shilling; David Feifel
Journal:  CNS Drugs       Date:  2016-03       Impact factor: 5.749

5.  A Psychometric Comparison of the Clinical Assessment Interview for Negative Symptoms and the Brief Negative Symptom Scale.

Authors:  Gregory P Strauss; James M Gold
Journal:  Schizophr Bull       Date:  2016-05-12       Impact factor: 9.306

6.  Sex differences in hedonic judgement of odors in schizophrenia cases and healthy controls.

Authors:  Julie Walsh-Messinger; Philip S Wong; Daniel Antonius; Kevin McMahon; Lewis A Opler; Paul Michael Ramirez; Dolores Malaspina
Journal:  Psychiatry Res       Date:  2018-08-20       Impact factor: 3.222

7.  The Neurobiological Basis for Social Affiliation in Autism Spectrum Disorder and Schizophrenia.

Authors:  Amanda Crider; Anilkumar Pillai
Journal:  Curr Behav Neurosci Rep       Date:  2016-04-16

8.  Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Authors:  Leah H Rubin; Jessica J Connelly; James L Reilly; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; Anthony C Ruocco; Sarah K Keedy; Ian Matthew; Neeraj Tandon; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Elliot S Gershon; Matcheri S Keshavan; Jeffrey R Bishop; John A Sweeney
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2015-11-09

9.  Normal sexual dimorphism in theory of mind circuitry is reversed in Schizophrenia.

Authors:  Julie Walsh-Messinger; Christine Stepanek; Julia Wiedemann; Deborah Goetz; Raymond R Goetz; Dolores Malaspina
Journal:  Soc Neurosci       Date:  2018-10-29       Impact factor: 2.083

10.  LC-MS/MS measurement of endogenous oxytocin in the posterior pituitary and CSF of macaques: A pilot study.

Authors:  D W Erikson; S W Blue; A V Kaucher; T A Shnitko
Journal:  Peptides       Date:  2021-03-31       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.